Winton Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-29,121
| Closed | -$5.74M | – | 647 |
|
2024
Q3 | $5.74M | Buy |
29,121
+27,020
| +1,286% | +$5.32M | 0.4% | 65 |
|
2024
Q2 | $434K | Buy |
+2,101
| New | +$434K | 0.03% | 441 |
|
2021
Q2 | – | Sell |
-1,050
| Closed | -$304K | – | 1432 |
|
2021
Q1 | $304K | Sell |
1,050
-1,140
| -52% | -$330K | 0.02% | 1134 |
|
2020
Q4 | $547K | Buy |
+2,190
| New | +$547K | 0.04% | 750 |
|
2020
Q3 | – | Sell |
-5,328
| Closed | -$929K | – | 1492 |
|
2020
Q2 | $929K | Sell |
5,328
-16,014
| -75% | -$2.79M | 0.02% | 993 |
|
2020
Q1 | $2.69M | Buy |
+21,342
| New | +$2.69M | 0.07% | 466 |
|
2019
Q4 | – | Sell |
-23,211
| Closed | -$3.07M | – | 1585 |
|
2019
Q3 | $3.07M | Sell |
23,211
-41,046
| -64% | -$5.43M | 0.04% | 422 |
|
2019
Q2 | $9.12M | Sell |
64,257
-9,264
| -13% | -$1.31M | 0.18% | 179 |
|
2019
Q1 | $10.7M | Sell |
73,521
-14,433
| -16% | -$2.1M | 0.21% | 182 |
|
2018
Q4 | $9.96M | Buy |
87,954
+5,328
| +6% | +$603K | 0.21% | 207 |
|
2018
Q3 | $11.1M | Buy |
+82,626
| New | +$11.1M | 0.23% | 175 |
|
2018
Q2 | – | Sell |
-57,049
| Closed | -$6.09M | – | 1038 |
|
2018
Q1 | $6.09M | Buy |
57,049
+940
| +2% | +$100K | 0.17% | 180 |
|
2017
Q4 | $6.14M | Sell |
56,109
-108,443
| -66% | -$11.9M | 0.18% | 172 |
|
2017
Q3 | $17.8M | Buy |
164,552
+6,289
| +4% | +$679K | 0.57% | 43 |
|
2017
Q2 | $16M | Buy |
+158,263
| New | +$16M | 0.47% | 58 |
|
2015
Q1 | – | Sell |
-7,237
| Closed | -$461K | – | 434 |
|
2014
Q4 | $461K | Sell |
7,237
-12,888
| -64% | -$821K | 0.01% | 548 |
|
2014
Q3 | $1.2M | Sell |
20,125
-2,672
| -12% | -$160K | 0.01% | 502 |
|
2014
Q2 | $1.22M | Buy |
+22,797
| New | +$1.22M | 0.01% | 507 |
|